Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Viruses · 26.09.2023 · 15 (10) · 1994
DOI: 10.3390/v15101994 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Viruses, online erschienen am 26.09.2023. Verfasst von Zhilu Yuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Architecture and Urban Planning, Research Institute for Smart Cities, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Technology Research Project of Shenzhen City.
Abstract (Originalsprache)
Due to the variation in the SARS-CoV-2 virus, COVID-19 exhibits significant variability in severity. This presents challenges for governments in managing the allocation of healthcare resources and prioritizing health interventions. Clinical severity is also a critical statistical parameter for researchers to quantify the risks of infectious disease, model the transmission of COVID-19, and provide some targeted measures to control the pandemic. To obtain more accurate severity estimates, including confirmed case-hospitalization risk, confirmed case-fatality risk, hospitalization-fatality risk, and hospitalization-ICU risk, we conducted a systematic review and meta-analysis on the clinical severity (including hospitalization, ICU, and fatality risks) of different variants during the period of COVID-19 mass vaccination and provided pooled estimates for each clinical severity metric. All searches were carried out on 1 February 2022 in PubMed for articles published from 1 January 2020 to 1 February 2022. After identifying a total of 3536 studies and excluding 3523 irrelevant studies, 13 studies were included. The severity results show that the Delta and Omicron variants have the highest (6.56%, 0.46%, 19.63%, and 9.06%) and lowest severities (1.51%, 0.04%, 6.01%, and 3.18%), respectively, according to the four clinical severity metrics. Adults over 65 have higher severity levels for all four clinical severity metrics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Architecture and Urban Planning, Research Institute for Smart Cities, Shenzhen University, Shenzhen 518060, China.
- College of Computer Science and Software Engineering, Shenzhen University, Shenzhen 518060, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Technology Research Project of Shenzhen City
- Guangdong Science and Technology Strategic Innovation Fund
Zitieren
APA
Yuan, Z., Shao, Z., Ma, L., & Guo, R. (2023). Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis. Viruses, 15(10), 1994. https://doi.org/10.3390/v15101994
Vancouver
Yuan Z, Shao Z, Ma L, Guo R. Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis. Viruses. 2023;15(10):1994. doi:10.3390/v15101994
BibTeX
@article{Yuan2023,
author = {Yuan, Zhilu and Shao, Zengyang and Ma, Lijia and Guo, Renzhong},
title = {Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis},
journal = {Viruses},
year = {2023},
volume = {15},
number = {10},
pages = {1994},
doi = {10.3390/v15101994}
}
EUVIMED